| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |